Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

  • Showing results for matteo bare. Your search for Matteo Baire retrieved no results.

Drug-eluting compared to bare metal stents in patients with end-stage renal disease on dialysis: a meta-analysis.

Galiffa VA, Crimi G, Gritti V, Scotti V, Ferrario M, Repetto A, Ferlini M, Marinoni B, De Ferrari GM, De Servi S, Sante Bongo A, Oltrona Visconti L, Klersy C.

J Cardiovasc Med (Hagerstown). 2019 May;20(5):313-320. doi: 10.2459/JCM.0000000000000755.


The "Destino-guided BEVAR" to Catheterize Downward Branches from a Femoral Access: Technical Note and Case Report.

Orrico M, Ronchey S, Setacci C, Marino M, Vona A, Lorido A, Nesi F, Giaquinta A, Mangialardi N.

Ann Vasc Surg. 2019 May;57:266-271. doi: 10.1016/j.avsg.2018.09.044. Epub 2019 Jan 24.


The "bare branch" for safe spinal cord ischemia prevention after total endovascular repair of thoracoabdominal aneurysms.

Orrico M, Ronchey S, Setacci C, Vona A, Marino M, Nesi F, Giaquinta A, Mangialardi N.

J Vasc Surg. 2019 Jun;69(6):1655-1663. doi: 10.1016/j.jvs.2018.09.027. Epub 2018 Nov 26.


Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.

Gargiulo G, Patialiakas A, Piccolo R, Thury A, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Ferlini M, Liistro F, Dellavalle A, Vranckx P, Briguori C, Windecker S, Valgimigli M.

Int J Cardiol. 2019 Feb 15;277:60-65. doi: 10.1016/j.ijcard.2018.09.120. Epub 2018 Oct 2.


Parametric transitions between bare and vegetated states in water-driven patterns.

Bertagni MB, Perona P, Camporeale C.

Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8125-8130. doi: 10.1073/pnas.1721765115. Epub 2018 Jul 23.


Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis.

Crimi G, Gritti V, Galiffa VA, Scotti V, Leonardi S, Ferrario M, Ferlini M, De Ferrari GM, Oltrona Visconti L, Klersy C.

J Interv Cardiol. 2018 Jun;31(3):319-329. doi: 10.1111/joic.12473. Epub 2017 Dec 28. Review.


Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ.

N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28.


Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients.

Quaretti P, Galli F, Moramarco LP, Corti R, Leati G, Fiorina I, Tinelli C, Montagna G, Maestri M.

Vasc Endovascular Surg. 2016 May;50(4):221-30. doi: 10.1177/1538574416639149. Epub 2016 Apr 19.


Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.

Ariotti S, Adamo M, Costa F, Patialiakas A, Briguori C, Thury A, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Ferlini M, Vranckx P, Valgimigli M; ZEUS Investigators.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):426-36. doi: 10.1016/j.jcin.2015.11.015.


Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.

Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators.

Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1.


Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.

Valgimigli M, Patialiakas A, Thury A, McFadden E, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Airoldi F, Ferlini M, Liistro F, Dellavalle A, Vranckx P, Briguori C; ZEUS Investigators.

J Am Coll Cardiol. 2015 Mar 3;65(8):805-815. doi: 10.1016/j.jacc.2014.11.053.


Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ.

Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18.


Efficacy of calcium channel blockers in the treatment of the myocardial bridging: a pilot study.

Alessandri N, Dei Giudici A, De Angelis S, Urciuoli F, Garante MC, Di Matteo A.

Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):829-34.


Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.

Tamburino C, Barbagallo R, Capodanno D, di Matteo S, Colombo GL, Recchia M, Ciriminna S; Sicilian DES Registry Investigators.

J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):322-9. doi: 10.2459/JCM.0b013e3283276ebb.


Life-threatening left main stenosis induced by compression from a dilated pulmonary artery.

Tespili M, Saino A, Personeni D, Silvestro A, Scopelliti P, Banfi C.

J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):183-7. doi: 10.2459/JCM.0b013e32831e3f9c.


Drug-eluting stents: from evidence to policy.

Marchetti M.

Expert Rev Med Devices. 2004 Sep;1(1):49-63. Review.


Supplemental Content

Loading ...
Support Center